文献速递新发突发、热带与寄生虫病

新型登革病毒抗体亲和力检测方法的开发及其在四价疫苗评估中的应用

Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine.
PubMed 文献 · J Infect Dis · 2022-01-01

本研究开发了一种基于生物膜干涉技术和登革病毒样颗粒的新型抗体亲和力检测方法,并用于评估四价登革疫苗TAK-003在两项2期临床试验中诱导的抗体应答。接种疫苗后亲和力指数升高并维持至1年,中和抗体滴度与亲和力指数总体不相关,但在亲和力成熟度最高的受试者中两者相关。

要点

  • 新型亲和力检测法可用于评估多克隆血清抗体对病毒样颗粒的亲和成熟。
  • TAK-003接种后亲和力指数升高并维持至少1年。
  • 中和抗体与亲和力指数仅在高亲和力成熟者中相关。

核心结论

  • TAK-003疫苗接种可刺激多克隆抗体亲和力成熟及功能性抗体应答,包括中和抗体。

研究设计与样本

  • 研究开发了一种基于生物膜干涉技术和登革病毒样颗粒的新型抗体亲和力检测法,先用抗登革单克隆抗体验证,再在两项2期临床试验中评估儿童、青少年和成人接种TAK-003后的抗体亲和力。

主要发现

  • 接种疫苗后亲和力指数升高,且亲和力在接种后1年内保持高位。
  • 中和抗体滴度与亲和力指数总体不相关。
  • 在抗体亲和力成熟度最高的受试者中,中和抗体滴度与亲和力指数存在相关性。

临床怎么用

  • 该检测法可用于评估登革疫苗诱导的抗体亲和力成熟,辅助评价疫苗免疫原性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Antibody affinity maturation is a critical step in development of functional antiviral immunity; however, accurate measurement of affinity maturation of polyclonal serum antibody responses to particulate antigens such as virions is challenging. We describe a novel avidity assay employing biolayer interferometry and dengue virus-like particles. After validation using anti-dengue monoclonal antibodies, the assay was used to assess avidity of antibody responses to a tetravalent dengue vaccine candidate (TAK-003) in children, adolescents, and adults during two phase 2 clinical trials conducted in dengue-endemic regions. Vaccination increased avidity index and avidity remained high through 1 year postvaccination. Neutralizing antibody titers and avidity index did not correlate overall; however, a correlation was observed between neutralizing antibody titer and avidity index in those subjects with the highest degree of antibody affinity maturation. Therefore, vaccination with TAK-003 stimulates polyclonal affinity maturation and functional antibody responses, including neutralizing antibodies. CLINICAL TRIALS REGISTRATION: NCT01511250 and NCT02302066.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tsuji I, Dominguez D, Egan MA, et al. Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine. J Infect Dis. 2022. PMID: 33534885. doi:10.1093/infdis/jiab064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。